P2RX7, purinergic receptor P2X 7, 5027

N. diseases: 337; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028768
Disease: Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder
0.010 Biomarker disease BEFREE P2rx7 knockout mice displayed reduced OCD-related marble burying behaviour which was most pronounced in late adolescence/early adulthood. 31693933 2020
CUI: C0338831
Disease: Manic
Manic
0.010 Biomarker disease BEFREE Our results support the hypothesis that P2X7R plays a vital role in the pathophysiology of mania, possibly by modulating the dopaminergic pathway and astrogliosis, as reflected in the behavioral changes observed. 31729632 2020
CUI: C1719494
Disease: PERIODONTITIS, LOCALIZED AGGRESSIVE
PERIODONTITIS, LOCALIZED AGGRESSIVE
0.010 GeneticVariation disease BEFREE The data from these analyses support a possible biological relationship between P2RX7 genetic variants and inflammatory response in localized aggressive periodontitis patients. 31292966 2020
CUI: C0003886
Disease: Arthrogryposis
Arthrogryposis
0.010 AlteredExpression disease BEFREE While ADC and AMC samples showed higher expression of P2X4 and P2X7 than the control, statistically, HCC samples exhibited the most significant expression of both P2X4 and P2X7 receptors than control tissues. 31401785 2019
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.010 Biomarker group BEFREE In this review, we will succinctly discuss the biological characteristics and summarize the recent progress of the involvement of P2X7R in the development and pathogenesis of autoimmune diseases, as well as its clinical implications and therapeutic potential. 31181327 2019
CUI: C0005587
Disease: Depression, Bipolar
Depression, Bipolar
0.010 Biomarker disease BEFREE The activation of the ATP-gated P2RX7 (purinergic receptor P2X, ligand-gated ion channel, 7) produces microglial activation, a process which has been demonstrated in depression, bipolar disorder, and schizophrenia. 30664971 2019
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.010 Biomarker group BEFREE Purinergic receptor-based signaling holds the therapeutic potential based on its role in cell proliferation of several carcinomas. 31401785 2019
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.010 AlteredExpression disease BEFREE P2X7 gene is highly expressed in the heart and shows direct interaction with major candidate genes for HCM. 31152337 2019
CUI: C0015397
Disease: Disorder of eye
Disorder of eye
0.010 Biomarker group BEFREE Although agents that attenuate P2X7 receptor function have been in development for many years, no compound is currently approved for the treatment of eye disease. 30954685 2019
CUI: C0019693
Disease: HIV Infections
HIV Infections
0.010 Biomarker group BEFREE The ATP/P2X7 axis in human immunodeficiency virus infection of macrophages. 30901736 2019
CUI: C0022408
Disease: Arthropathy
Arthropathy
0.010 AlteredExpression group BEFREE In addition, the activation of P2X7 receptor can aggravate the process of some joint diseases such as osteoarthritis, rheumatoid arthritis, and acute gouty arthritis. 30317598 2019
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.010 Biomarker group BEFREE P2X7 PET Radioligand <sup>18</sup>F-PTTP for Differentiation of Lung Tumor from Inflammation. 30655332 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 Biomarker disease BEFREE In this study, we identified P2RX7 as a putative target of gastric cancer, which was overexpressed in gastric cancer tissues and had relationship with worse prognosis. 31042071 2019
CUI: C0026850
Disease: Muscular Dystrophy
Muscular Dystrophy
0.010 Biomarker disease BEFREE P2X7 purinoceptor as a therapeutic target in muscular dystrophies. 30901735 2019
CUI: C0028790
Disease: Cerebral artery occlusion
Cerebral artery occlusion
0.010 Biomarker disease BEFREE We present evidence that P2X7 may have a detrimental or beneficial role in the nervous system, in the context of neurological pathologies: epilepsy, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, age-related macular degeneration and cerebral artery occlusion. 31551714 2019
CUI: C0030201
Disease: Pain, Postoperative
Pain, Postoperative
0.010 GeneticVariation phenotype BEFREE Moreover, the patients carrying GA and AA genotypes needed more fentanyl to control pain within 48 hours after surgery (P < .05 for all).P2RX7 gene rs1718125 polymorphism is significantly associated with postoperative pain and fentanyl consumption in patients with lung cancer. 30762755 2019
CUI: C0030499
Disease: Parasitic Diseases
Parasitic Diseases
0.010 Biomarker group BEFREE Here, we discuss key points from the recent literature regarding P2X7 receptor activation during intracellular parasite infections. 30901737 2019
CUI: C0031046
Disease: Pericarditis
Pericarditis
0.010 GeneticVariation disease BEFREE The Hardy-Weinberg Equilibrium (HWE) analysis was used to detect the association of P2RX7 489C>T SNP with SLE complicated with pericarditis. 31376246 2019
CUI: C0031090
Disease: Periodontal Diseases
Periodontal Diseases
0.010 Biomarker group BEFREE We and others have reported that the purinergic P2X7 receptor plays a role in the modulation of periodontal disease and intracellular pathogen control. 31341421 2019
CUI: C0032584
Disease: polyps
polyps
0.010 AlteredExpression phenotype BEFREE The mRNA expressions of M1, M3 and P2X7 were significantly lower and that of pannexin-1 tended to be lower in the polyp than in the turbinate. 30762948 2019
CUI: C0035309
Disease: Retinal Diseases
Retinal Diseases
0.010 Biomarker group BEFREE Targeting P2X7 receptors as a means for treating retinal disease. 30954685 2019
CUI: C0037274
Disease: Dermatologic disorders
Dermatologic disorders
0.010 GeneticVariation group BEFREE The role of the P2X7 receptor (P2X7R) has never been investigated in hidradenitis suppurativa (HS), which is a recurrent skin disease characterized by inflammatory nodules, scarring, and suppuration. 31454821 2019
CUI: C0085315
Disease: Toxoplasmosis, Cerebral
Toxoplasmosis, Cerebral
0.010 Biomarker disease BEFREE To understand the contribution of P2X7 during cerebral toxoplasmosis, wild-type and P2rx7 knockout mice were infected orally with T. gondii and their pathologic profiles were analyzed. 30653952 2019
CUI: C0151825
Disease: Bone pain
Bone pain
0.010 Biomarker phenotype BEFREE In this study we tested the analgesic potential of AFC5261, a selective P2X7R antagonist, in a rat model of cancer-induced bone pain to evaluate if the opposing pro- and anti-nociceptive effects could be a consequence of long vs. short term inhibition of the P2X7R. 30582910 2019
CUI: C0158252
Disease: Intervertebral disc disorder
Intervertebral disc disorder
0.010 Biomarker group BEFREE To elaborate the mechanism of miR-150 in the regulation of the NF-κB signal pathway in intervertebral disc degeneration (IDD) by targeting P2X7. 31726456 2019